Back to top

Regeneron price target raised to $737 from $696 at RBC Capital

RBC Capital raised the firm’s price target on Regeneron (REGN) to $737 from $696 and keeps a Sector Perform rating on the shares. The company repor...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Regeneron Pharmaceuticals, Inc. (REGN)

Banco Santander, S.A. (SAN)

Sanofi (SNY)